Skip to content

precision medicine

  • 2 min read

    TIME names BC Platforms as ‘Outstanding’ in World’s Top HealthTech Companies 2025 list

    Recognizing our leadership in AI, data analytics and Real-World Data.

    Read more
  • 3 min read

    BC Platforms joins BRECISE to advance biomarkers research for precision oncology for prostate and bladder cancers

    We join BRECISE, a major cancer research initiative advancing biomarker development to improve diagnosis, treatment and personalized care across Europe.

    Read more